![Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis](https://www.mdpi.com/cells/cells-08-00927/article_deploy/html/images/cells-08-00927-g001.png)
Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
![CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation | Scientific Reports CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-57293-y/MediaObjects/41598_2019_57293_Fig7_HTML.png)
CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation | Scientific Reports
![IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells](https://pub.mdpi-res.com/ijms/ijms-22-11302/article_deploy/html/images/ijms-22-11302-g001.png?1634780568)
IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells
![CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610819301011-fx1.jpg)
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect
![CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41423-021-00734-4/MediaObjects/41423_2021_734_Fig1_HTML.png)
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology
![The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease | Journal of Cardiovascular Translational Research The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease | Journal of Cardiovascular Translational Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12265-020-09994-3/MediaObjects/12265_2020_9994_Fig2_HTML.png)
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease | Journal of Cardiovascular Translational Research
![The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets | eLife The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets | eLife](https://iiif.elifesciences.org/lax/44245%2Felife-44245-fig8-v2.tif/full/1500,/0/default.jpg)
The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets | eLife
![The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease | Journal of Cardiovascular Translational Research The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease | Journal of Cardiovascular Translational Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12265-020-09994-3/MediaObjects/12265_2020_9994_Fig1_HTML.png)